Article Text

Download PDFPDF

Exploring patients’ understanding of antibiotic resistance and how this may influence attitudes towards antibiotic use for acute respiratory infections: a qualitative study in Australian general practice
  1. Mina Bakhit,
  2. Chris Del Mar,
  3. Elizabeth Gibson,
  4. Tammy Hoffmann
  1. Centre for Research in Evidence-Based Practice, Gold Coast, Queensland, Australia
  1. Correspondence to Professor Tammy Hoffmann; thoffman{at}bond.edu.au

Abstract

Objectives To explore patients’ or parents of child patients’ understanding of antibiotic resistance and aspects of resistance such as resistance reversibility and its spread among those in close proximity, along with how this may influence attitudes towards antibiotic use for acute respiratory infections (ARIs).

Design Qualitative semistructured interview study using convenience sampling and thematic analysis by two researchers independently.

Setting General practices in Gold Coast, Australia.

Participants 32 patients or parents of child patients presenting to general practice with an ARI.

Results Five themes emerged: (1) antibiotic use is seen as the main cause of antibiotic resistance, but what it is that becomes resistant is poorly understood; (2) resistance is perceived as a future ‘big problem’ for the community, with little appreciation of the individual impact of or contribution to it; (3) poor awareness that resistance can spread between family members but concern that it can; (4) low awareness that resistance can decay with time and variable impact of this knowledge on attitudes towards future antibiotic use and (5) antibiotics are perceived as sometimes necessary, with some awareness and consideration of their harms.

Conclusions Patients’ or parents of child patients’ understanding of antibiotic resistance and aspects of it was poor. Targeting misunderstandings about resistance in public health messages and clinical consultations should be considered as part of a strategy to improve knowledge about it, which may encourage more consideration about antibiotic use for illnesses such as ARIs.

  • antibiotics
  • antibiotic resistance
  • primary care
  • respiratory tract infections
  • antibiotic resistance decay

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MB, TH and CDM designed the study. MB recruited and interviewed participants. MB, EG, TH and CDM analysed the data. MB drafted the original manuscript and EG, TH and CDM contributed to writing and revising the manuscript. All authors read and approved the final manuscript.

  • Funding Funding for a PhD scholarship for the lead author was provided by the Australian National Health and Medical Research Council through a research grant for the Centre for Research Excellence in Minimising Antibiotic Resistance from Acute Respiratory Infections (#1044904).

  • Disclaimer Centre for Research Excellence in Minimising Antibiotic Resistance from Acute Respiratory Infections had no role in study design, data collection, data analysis, data interpretation or writing of the report.

  • Competing interests None declared.

  • Ethics approval Ethical approval was provided by the Human Research Ethics Committee at Bond University (#0000015433).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.

  • Patient consent for publication Not required.